Access cutting-edge advanced solid tumors treatment through this clinical trial at a research site in Santa Monica. Study-provided care at no cost to qualified participants.
Access advanced solid tumors specialists in Santa Monica at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced solid tumors treatment provided free
BOLD-100 is an intravenously administered sterile solution containing the ruthenium-based small molecule. BOLD-100 has been shown to preferentially decrease the expression of GRP78 in tumour cells and ER stressed cells when compared to normal cells. BOLD-100 will be combined with cytotoxic FOLFOX chemotherapy in this study, with a dose escalation cohort to ensure tolerability and safety, followed by a cohort expansion phase.
Sponsor: Bold Therapeutics, Inc.
Check if you qualify for this advanced solid tumors clinical trial in Santa Monica, CA
If you're searching for advanced solid tumors treatment options in Santa Monica, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Santa Monica research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.